Valuation: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Capitalization 34.07B 4.65B 4.51B 4.25B 3.81B 6.67B 402B 7.51B 52B 19.27B 165B 17.44B 17.07B 735B P/E ratio 2024 *
54.2x
P/E ratio 2025 * 47.3x
Enterprise value 33.55B 4.58B 4.45B 4.18B 3.75B 6.57B 396B 7.39B 51.21B 18.98B 162B 17.18B 16.81B 723B EV / Sales 2024 *
8.29x
EV / Sales 2025 * 7.15x
Free-Float
37.38%
Yield 2024 *
0.33%
Yield 2025 * 0.92%
More valuation ratios * Estimated data
Dynamic Chart
1 day+5.82%
1 week+2.00%
Current month-1.20%
1 month-10.04%
3 months-12.13%
6 months+9.53%
Current year-1.20%
More quotes
1 week
28.53
Extreme 28.53
30.67
1 month
28.53
Extreme 28.53
33.89
Current year
28.53
Extreme 28.53
31.24
1 year
23.50
Extreme 23.5
38.10
3 years
20.00
Extreme 20
39.33
5 years
16.70
Extreme 16.7
43.66
10 years
16.70
Extreme 16.7
46.32
More quotes
Director TitleAgeSince
Chief Executive Officer 52 2022-09-22
Director of Finance/CFO 52 2021-12-29
Chief Administrative Officer 49 2005-12-31
Manager TitleAgeSince
Chairman 81 1998-11-02
Chairman 50 2022-09-22
Director/Board Member 49 2010-08-19
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+5.82%+2.00%+1.87%+16.82%4.65B
-0.88%-4.50%+32.03%+105.71%49.1B
+0.15%-4.11%+36.55%+94.38%27.36B
+0.87%+1.68%+34.76% - 18.47B
-0.04%-3.15%+10.25%+59.06%13.51B
-1.53%+0.36%+37.41%+124.86%11.63B
-.--%+0.14% - - 6.79B
-.--%-1.95% - - 5.73B
-2.60%-9.24%+62.28%+185.80%4.94B
-0.34%-0.37%-39.24%-41.72%4.86B
Average +0.15%-1.61%+21.99%+77.85% 14.7B
Weighted average by Cap. -0.20%-2.71%+29.09%+93.21%
See all sector performances

Financials

2024 *2025 *
Net sales 4.05B 552M 536M 505M 453M 792M 47.76B 892M 6.17B 2.29B 19.58B 2.07B 2.03B 87.22B 4.52B 616M 598M 563M 505M 885M 53.31B 995M 6.89B 2.56B 21.86B 2.31B 2.26B 97.37B
Net income 629M 85.75M 83.3M 78.4M 70.32M 123M 7.42B 139M 959M 356M 3.04B 322M 315M 13.55B 719M 98.1M 95.3M 89.69M 80.45M 141M 8.49B 158M 1.1B 407M 3.48B 368M 360M 15.51B
Net Debt -520M -70.89M -68.87M -64.82M -58.14M -102M -6.13B -115M -793M -294M -2.52B -266M -260M -11.21B -1.76B -240M -233M -219M -196M -344M -20.73B -387M -2.68B -994M -8.5B -899M -880M -37.87B
More financial data * Estimated data
Logo Shenzhen Salubris Pharmaceuticals Co., Ltd.
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company is also engaged in the research and development, production and sales of cardiovascular medical devices. The Company distributes its products within domestic market and to overseas markets.
Employees
3,517
More about the company
Date Price Change Volume
25-01-14 30.56 ¥ +5.82% 8,117,389
25-01-13 28.88 ¥ -0.10% 4,285,971
25-01-10 28.91 ¥ 0.00% 4,504,022
25-01-09 28.91 ¥ +0.17% 5,223,400
25-01-08 28.86 ¥ -3.67% 10,411,180

End-of-day quote Shenzhen S.E., January 13, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
surperformance-ratings-light-chart SHENZHEN-SALUBRIS-PHARMACMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.56CNY
Average target price
40.09CNY
Spread / Average Target
+31.18%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002294 Stock